PROTOTHECOSIS

PROTOTHECOSIS was reported 94 times

PROTOTHECOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 26 0.0032
1 Lipopeptide Antibacterial [EPC] 24 0.0025
2 Lipid-based Polyene Antifungal [EPC] 21 0.0016
3 Penem Antibacterial [EPC] 27 0.0008
4 Polyene Antifungal [EPC] 21 0.0005
5 BCL-2 Inhibitor [EPC] 25 0.0004
6 Calcineurin Inhibitor Immunosuppressant [EPC] 41 0.0003
7 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0003
8 Azole Antifungal [EPC] 42 0.0003
9 Human Immunoglobulin G [EPC] 5 0.0002
10 Fluoroquinolone Antibacterial [EPC] 21 0.0002
11 Mood Stabilizer [EPC] 28 0.0001
12 Anti-epileptic Agent [EPC] 28 0.0001
13 Cephalosporin Antibacterial [EPC] 1 0.0001
14 Nucleoside Metabolic Inhibitor [EPC] 27 0.0001
15 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
16 Corticosteroid [EPC] 72 0.0001
17 Alkaloid [EPC] 1 0.0000
18 Thalidomide Analog [EPC] 15 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
21 Macrolide Antimicrobial [EPC] 1 0.0000
22 Alkylating Drug [EPC] 4 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 15 0.0000
24 Tetracycline-class Drug [EPC] 1 0.0000
25 Leukocyte Growth Factor [EPC] 2 0.0000
26 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
27 Kinase Inhibitor [EPC] 7 0.0000
28 Microtubule Inhibitor [EPC] 2 0.0000
29 Nucleoside Analog Antiviral [EPC] 1 0.0000
30 Osmotic Laxative [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000